Skip to Main Content

KMAP BULLETIN: Preferred Drug List Update – August 2025

Date: 08/12/25

KMAP GENERAL BULLETIN 25187 (PDF)

Effective with dates of service on or after August 1, 2025, the following medications will become Non-Preferred: 

  • Khindivi® (hydrocortisone)
  • Brynovin (sitagliptin HCL)
  • Merilog™ Solostar (insulin aspart-szjj)
  • Merilog™ (insulin aspart-szjj)
  • Xifyrm™ (meloxicam)
  • Ryzneuta® (efbemalenograstim Alfa-vuxw)
  • Xphozah® (tenapanor)
  • Yutrepia™ (treprostinil )


Effective with dates of service on or after August 1, 2025, the following medication will be added as Preferred: 

  • Valsartan®  (Labeler 72888) Oral Solution


Note: The effective date of the policy is August 1, 2025. The implementation of State policy by the KanCare Managed Care Organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates once the policy is implemented.